Impact Assessment Needed

Tuesday, March 21, 2006

U.S. FDA and EPA seemed to be quite advanced in nanotech oversight. In Switzerland and Germany, only two of the 32 companies had investigated the effects of absorption of nanoparticles by living organisms.
"One reason for this lack of risk assessment is that companies and researchers do not know what they should do. There are no industry standards or government regulations yet"
A good news is that The Swiss Environment Office and the Federal Health Office  will aim to present proposals by the end of the year to set up a national action plan including proposals for risk assessment and risk management of nanomaterials and examine its compatibility with  European Union and Organisation for Economic Cooperation and Development (OECD) guidelines.

I haver never read the EU and OECD guidelines. I'll try to compare it with the EPA/FDA's and see if we can discuss it here.

Mohamad Mova Al 'Afghani